National Institute on Drug Abuse; Notice of Meeting, 104554-104555 [2024-30570]
Download as PDF
<![CDATA[
104554
Federal Register / Vol. 89, No. 246 / Monday, December 23, 2024 / Notices
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Alzheimer’s
Disease Drug Development Program.
Date: January 23, 2025.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Mariel Jais, PharmD,
Scientific Review Officer, National Institute
of Aging, National Institute of Health, 5601
Fishers Lane, Room 2E400, Rockville, MD
20852, (301) 594–2614, mariel.jais@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 17, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30555 Filed 12–20–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
khammond on DSK9W7S144PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; R03 Medical
Transition to Aging Research.
Date: February 18, 2025.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Ivan Tadeu Rebustini,
Ph.D., Scientific Review Officer, National
Institute of Aging, National Institute of
Health, 5601 Fishers Lane, Room 100,
VerDate Sep<11>2014
17:03 Dec 20, 2024
Jkt 265001
Rockville, MD 20852, (301) 555–1212,
ivan.rebustini@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 17, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30559 Filed 12–20–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; SWAN.
Date: February 28, 2025.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Rajasri Roy, Ph.D., MPH,
Scientific Review Officer, National Institute
of Aging, National Institute of Health, 5601
Fishers Lane, Room 100, Rockville, MD
20852, (301) 496–9666, rajasri.roy@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 17, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30562 Filed 12–20–24; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council on Drug Abuse.
The meeting will be held as a virtual
meeting and is open to the public, as
indicated below. Individuals who plan
to view the virtual meeting and need
special assistance such as sign language
interpretation or other reasonable
accommodations to view the meeting,
should notify Dr. Gillian Acca via email
at gillian.acca@nih.gov five days in
advance of the meeting. The open
session will be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
A portion of the meeting will be
closed to the public in accordance with
the provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The intramural programs
and projects as well as the grant
applications and/or contract proposals
and the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with intramural
programs and projects as well as the
grant applications and/or contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Drug Abuse.
Date: February 4, 2025.
Closed: 10:30 a.m. to 11:45 a.m.
Agenda: To review and evaluate grant
applications.
Closed: 11:45 a.m. to 12:15 p.m.
Agenda: Report to Council from the NIDA
Board of Scientific Counselors (BSC).
Open: 1:00 p.m. to 5:00 p.m.
Agenda: Presentations and other business
of the Council.
Address: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Susan R.B. Weiss, Ph.D.,
Director, Division of Extramural Research,
Office of the Director, National Institute on
Drug Abuse, NIH, Three White Flint North,
RM 09D08, 11601 Landsdown Street,
Bethesda, MD 20852, 301–443–6480, sweiss@
nida.nih.gov.
Contact Person: Gillian Acca, Ph.D., Health
Science Policy Analyst, Division of
Extramural Research, Office of Extramural
Policy, National Institute on Drug Abuse,
NIH, Three White Flint North, RM 09C70,
E:\FR\FM\23DEN1.SGM
23DEN1
Federal Register / Vol. 89, No. 246 / Monday, December 23, 2024 / Notices
11601 Landsdown Street, Bethesda, MD
20852, 301–827–5863, gillian.acca@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to Dr. Gillian Acca via email
at gillian.acca@nih.gov. The statement
should include the name, address, telephone
number and when applicable, the business or
professional affiliation of the interested
person.
Information is also available on the
Institute’s/Center’s home page:
www.drugabuse.gov/NACDA/
NACDAHome.html, where an agenda and
any additional information for the meeting
will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: December 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30570 Filed 12–20–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
khammond on DSK9W7S144PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Factors
influencing Cognitive Impairment.
Date: February 20, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
VerDate Sep<11>2014
17:03 Dec 20, 2024
Jkt 265001
104555
Contact Person: Thomas John O’Farrell,
Ph.D., Scientific Review Officer National
Institute of Aging, National Institute of
Health, 5601 Fishers Lane, Suite 8B,
Rockville, MD 20852, (301) 402–8559,
tom.ofarrell@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 17, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
[FR Doc. 2024–30561 Filed 12–20–24; 8:45 am]
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; NIA IMPACT
Collaboratory.
Date: February 3, 2025.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute on Aging, 5601
Fishers Lane, Suite 8B, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Sandhya Sanghi, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, 5601
Fishers Lane, 2N230, Rockville, MD 20852,
(301) 496–2879, sandhya.sanghi@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 17, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30567 Filed 12–20–24; 8:45 am]
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Partnerships for the
Development of Tools to Advance
Therapeutic Discovery for Select AntibioticResistant Gram-Negative Bacteria (R01
Clinical Trial Not Allowed).
Date: January 28, 2025.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F21B,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Maryam Feili-Hariri,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F21B,
Rockville, MD 20892, 240–669–5026,
haririmf@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–30569 Filed 12–20–24; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
E:\FR\FM\23DEN1.SGM
23DEN1
]]>Agencies
[Federal Register Volume 89, Number 246 (Monday, December 23, 2024)]
[Notices]
[Pages 104554-104555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30570]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council on Drug Abuse.
The meeting will be held as a virtual meeting and is open to the
public, as indicated below. Individuals who plan to view the virtual
meeting and need special assistance such as sign language
interpretation or other reasonable accommodations to view the meeting,
should notify Dr. Gillian Acca via email at [email protected] five
days in advance of the meeting. The open session will be videocast and
can be accessed from the NIH Videocasting and Podcasting website
(https://videocast.nih.gov/).
A portion of the meeting will be closed to the public in accordance
with the provisions set forth in sections 552b(c)(4) and 552b(c)(6),
title 5 U.S.C., as amended. The intramural programs and projects as
well as the grant applications and/or contract proposals and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with intramural programs and projects
as well as the grant applications and/or contract proposals, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Advisory Council on Drug Abuse.
Date: February 4, 2025.
Closed: 10:30 a.m. to 11:45 a.m.
Agenda: To review and evaluate grant applications.
Closed: 11:45 a.m. to 12:15 p.m.
Agenda: Report to Council from the NIDA Board of Scientific
Counselors (BSC).
Open: 1:00 p.m. to 5:00 p.m.
Agenda: Presentations and other business of the Council.
Address: National Institutes of Health, National Institute on
Drug Abuse, 301 North Stonestreet Avenue, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Susan R.B. Weiss, Ph.D., Director, Division of
Extramural Research, Office of the Director, National Institute on
Drug Abuse, NIH, Three White Flint North, RM 09D08, 11601 Landsdown
Street, Bethesda, MD 20852, 301-443-6480, [email protected].
Contact Person: Gillian Acca, Ph.D., Health Science Policy
Analyst, Division of Extramural Research, Office of Extramural
Policy, National Institute on Drug Abuse, NIH, Three White Flint
North, RM 09C70,
[[Page 104555]]
11601 Landsdown Street, Bethesda, MD 20852, 301-827-5863,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to Dr. Gillian Acca via email
at [email protected]. The statement should include the name,
address, telephone number and when applicable, the business or
professional affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.drugabuse.gov/NACDA/NACDAHome.html, where an agenda and
any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: December 18, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-30570 Filed 12-20-24; 8:45 am]
BILLING CODE 4140-01-P
